Hewlett Packard Enterprise Surges After Strong Earnings
Friday’s market rebound was highlighted by a 12.4% jump in Hewlett Packard Enterprise (HPE) shares, fueled by the company’s robust earnings report released last week. This performance boosted investor confidence and helped HPE enter the IBD Large Cap 20 list, underscoring its solid market position and growth outlook.
Apple Gains on New Product Launches
Apple Inc. (AAPL) contributed to the rally with its shares rising nearly 2% on Friday, adding up to a roughly 4% gain over the week. The enthusiasm is linked to Apple’s recent unveiling of multiple products, including its first foldable iPhone model named Duo and an upgraded AI-powered Siri voice assistant. Apple’s current composite rating stands at a full 99, reflecting strong fundamentals and technicals.
Diverse Companies Featured in Updated IBD Growth Stock Lists
Energy transport firm Dorian LPG (LPG) reached a new high on Friday and was added to the IBD Stock Focus list. Mining company Harmony Gold (HMY) earned a spot among Sector Leaders thanks to solid recent performance. Additionally, Salesforce (CRM), known for enterprise software and AI innovation, was included in the IBD 50 growth stock lineup.
IBD’s Dynamic Screening Identifies Emerging Growth Leaders
IBD continues to update its stock screening methodology to identify stocks demonstrating early-stage strength in relative price momentum and fundamentals. This week, 20 new stocks were added across various IBD growth stock lists, helping investors pinpoint promising growth opportunities. Following these updates daily allows investors to stay aligned with market trends and potential breakout candidates.
Emphasizing Research Alongside IBD Guidance
While IBD’s selections offer valuable guidance for spotting quality growth stocks, investors are advised to incorporate their own analysis and adhere to disciplined buy rules. The recommended IBD investment process involves monitoring overall market conditions, evaluating stock potential, and timing entries and exits carefully to support informed decision-making. These list changes were current as of September 11, 2026, 5:50 p.m. Eastern Time.
The IBD 50 remains a flagship screening tool highlighting 50 stocks that exhibit strong relative strength and solid fundamentals, serving as a key resource for investors focused on growth stock opportunities.